Bruker Corporation
Bruker Corporation (NASDAQ: BRKR) is a developer, manufacturer, and distributor of high-performance scientific instruments and analytical and diagnostic solutions that enable customers to explore life and materials at microscopic, molecular, and cellular levels. The company's technology platforms include magnetic… From the company’s description.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What Bruker Corporation does
In the company’s own words
Bruker Corporation (NASDAQ: BRKR) is a developer, manufacturer, and distributor of high-performance scientific instruments and analytical and diagnostic solutions that enable customers to explore life and materials at microscopic, molecular, and cellular levels. The company's technology platforms include magnetic resonance, mass spectrometry, gas and liquid chromatography, X-ray, microscopy, metrology, and molecular spectroscopy technologies. Bruker's products and solutions address the needs of customers in life and materials science research, biopharmaceuticals, applied markets, microbiology, in-vitro diagnostics, and nanotechnology. The company maintains major technical and manufacturing centers in Europe and North America with sales offices located throughout the world. More information is available at www.bruker.com.
Bruker operates through four reportable segments. The BSI BioSpin segment focuses on magnetic resonance spectroscopy, preclinical imaging, biopharma and applied solutions, services and lifecycle support, integrated data solutions, and laboratory automation. The BSI CALID segment comprises life sciences mass spectrometry, applied mass spectrometry, microbiology and infection diagnostics, and optics divisions. The BSI NANO segment includes X-ray instruments, nano surfaces and metrology, spatial biology, fluorescence microscopy, and cellular analysis. The BEST segment designs and manufactures superconducting materials and related products for medical, research, and industrial applications.
The company's customer base includes academic and government research facilities, pharmaceutical and biotechnology companies, contract research organizations, hospitals, clinical laboratories, food and beverage companies, environmental testing facilities, and industrial manufacturers. Bruker's sales approach combines direct sales forces across North America, Europe, China, Japan, and the Asia Pacific region with indirect channels including international distributors and independent sales representatives. The company's sales cycles vary significantly by product type, ranging from two weeks to six months for industrial products to more than two years for large, complex high-end contracts.
Company details
- Sector
- Health Care
- Industry (SIC)
- Medical Instruments
- Headquarters
- BILLERICA, MA
- Fiscal year end
- December
- CIK
- 1109354
- SIC
- 3826
Financial performance, year by year
Fiscal 2013–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Bruker Corporation — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · Bruker Corporation’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Bruker Corporation and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Bruker Corporation's earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Bruker Corporation's last four quarterly filings that the numbers alone won't show?”